Connect with us

General news

NCDC deplores misinformation about monkeypox in Nigeria

Published

on

 The Nigeria Centre for Disease Control NCDC has decried what it described as widespread misinformation about the infection especially in Nigeria The Director General of the NCDC Ifedayo Adetifa said this on Tuesday at a virtual media dialogue on the infection Adetifa however admitted that there is an uptick in Monkeypox cases in Nigeria If not contained it could exceed the peak number of cases seen in 2017 when the infection re emerged Monkeypox is not a plot to cause lockdowns like COVID 19 and there is no evidence of the release of the virus from a laboratory he said He noted that more than 3 000 laboratory confirmed cases and one death have been recorded globally as of June 22 The NCDC said that the nearly 5 000 human infections with monkeypox that have been reported worldwide The NCDC DG said though rare Monkeypox was not a novel disease In Nigeria there has been no observed change in transmissibility of the virus nor changes in its clinical manifestation documented including symptoms profile and virulence nor is their evidence of sexual transmission Apart from misinformation discrimination and stigmatisation that comes with the Monkeypox infection needs urgent intervention across the globe Prevailing media perception and misinformation on monkeypox has fuelled false narratives about the virus and the potential risk of discrimination and stigmatisation from this requires urgent social and behaviour change intervention Since its sudden resurgence in 2017 he said a multi agency Technical Working Group TWG coordinated at the NCDC has led Nigeria s efforts to improve the detection prevention and control of monkeypox IImportantly we have gained a better understanding of the epidemiology of the virus to inform preparedness and response in country he said He said that genomic sequencing is ongoing at NCDC s National Reference Laboratory to identify possible mutations and the epidemiology of the virus According to him NCDC is supporting the global effort to respond to the disease as well as pushing for the renaming and re classification of the virus to a non discriminatory and non stigmatising nomenclature Monkeypox is a priority despite being neglected for years especially during outbreaks as we have had in Nigeria and neighbouring countries such as DRC a few years back While it is unfortunate that it takes such a global spread for the needed attention to be given here in Nigeria it has remained a priority for us he said Also speaking the WHO Country Representative Dr Walter Mulombo urged journalists to address misconceptions about Monkeypox disease which has continued to fuel false narratives about Nigeria globally What is important is to avert any potential inequitable access to vaccines experienced by African countries including Nigeria in the early stages of a pandemic he said Mulombo who was represented by the Deputy Country Rep Dr Alexander Chimbaru said that the rumours and misinformation would cause more harm and loss of lives than the monkeypox disease itself There s need for us all to have one coordinated response to monkeypox locally and globally to avoid it from becoming another pandemic Which by implication means equitable access to essential tools resources and information exchange Therefore what is extremely important now with monkeypox is to avert any potential for a repeat of the inequitable access to COVID 19 vaccines experienced by African countries including Nigeria early in the pandemic There has not been any use of smallpox vaccines for monkeypox outbreaks in Africa Since the eradication of smallpox small quantities of smallpox vaccines have been kept in a few national stockpiles They are very limited and not in use for vaccination he said He said that a new vaccine MVA BN against smallpox and monkeypox has been approved but is not yet widely available outside national stockpiles The News Agency of Nigeria reports that monkeypox has been reported in more than 40 countries outside of Africa where smallpox was virtually unknown until May 2022 According to the WHO from January to June 22 42 countries across five regions have reported a cumulative total of 3 413 confirmed cases with over 90 per cent recorded in non endemic countries The WHO European Region topped the infection with 2 933 cases representing 86 per cent of the total cases followed by the Region of the Americas with 381 amounting to 11 per cent The African Region came third on the log with 73 cases representing two per cent of the global cases reported from six countries with Nigeria topping the list Nigeria is followed by the Democratic Republic of the Congo the Central African Republic Ghana Cameroon and Congo Meanwhile the monkeypox emergency committee convened by the WHO began its deliberations in Geneva The experts represented therein must assess whether this is an emergency of international concern the highest alert level that the WHO can impose It last did this when Sars CoV 2 appeared on Jan 30 NewsSourceCredit NAN
NCDC deplores misinformation about monkeypox in Nigeria

Nigeria Centre for Disease Control

The Nigeria Centre for Disease Control (NCDC) has decried what it described as widespread misinformation about the infection, especially in Nigeria.

blogger outreach for seo naija papers

Ifedayo Adetifa

The Director-General of the NCDC, Ifedayo Adetifa, said this on Tuesday at a virtual media dialogue on the infection.

naija papers

Adetifa, however, admitted that there is an uptick in Monkeypox cases in Nigeria.

naija papers

“If not contained, it could exceed the peak number of cases seen in 2017 when the infection re-emerged.

“Monkeypox is not a plot to cause lockdowns like COVID-19 and there is no evidence of the release of the virus from a laboratory,” he said.

He noted that more than 3,000 laboratory-confirmed cases and one death have been recorded globally as of June 22.

The NCDC said that the nearly 5,000 human infections with monkeypox that have been reported worldwide.

NCDC DG

The NCDC DG said though rare, Monkeypox was not a novel disease.

“In Nigeria, there has been no observed change in transmissibility of the virus nor changes in its clinical manifestation documented (including symptoms, profile, and virulence) nor is their evidence of sexual transmission.

“Apart from misinformation, discrimination and stigmatisation that comes with the Monkeypox infection needs urgent intervention across the globe.

“Prevailing media perception and misinformation on monkeypox has fuelled false narratives about the virus, and the potential risk of discrimination and stigmatisation from this requires urgent social and behaviour change intervention.

Technical Working Group

Since its sudden resurgence in 2017, he said, a multi-agency Technical Working Group (TWG) coordinated at the NCDC has led Nigeria’s efforts to improve the detection, prevention, and control of monkeypox.

“IImportantly, we have gained a better understanding of the epidemiology of the virus to inform preparedness and response in-country,” he said.

National Reference Laboratory

He said that genomic sequencing is ongoing at NCDC’s National Reference Laboratory to identify possible mutations and the epidemiology of the virus.

According to him, NCDC is supporting the global effort to respond to the disease as well as pushing for the renaming and re-classification of the virus to a “non-discriminatory and non-stigmatising nomenclature”.

“Monkeypox is a priority despite being neglected for years, especially during outbreaks as we have had in Nigeria and neighbouring countries such as DRC a few years back.

“While it is unfortunate that it takes such a global spread for the needed attention to be given, here in Nigeria, it has remained a priority for us,” he said.

WHO Country Representative

Also speaking, the WHO Country Representative, Dr Walter Mulombo, urged journalists to address misconceptions about Monkeypox disease which has continued to fuel false narratives about Nigeria globally.

“What is important is to avert any potential inequitable access to vaccines experienced by African countries including Nigeria in the early stages of a pandemic,” he said.

Deputy Country Rep- Dr

Mulombo, who was represented by the Deputy Country Rep- Dr Alexander Chimbaru said that the rumours and misinformation would cause more harm and loss of lives than the monkeypox disease itself.

“There’s need for us all to have one coordinated response to monkeypox locally and globally to avoid it from becoming another pandemic. Which by implication, means equitable access to essential tools, resources and information exchange.

“Therefore, what is extremely important now with monkeypox is to avert any potential for a repeat of the inequitable access to COVID-19 vaccines experienced by African countries, including Nigeria, early in the pandemic.

“There has not been any use of smallpox vaccines for monkeypox outbreaks in Africa. Since the eradication of smallpox, small quantities of smallpox vaccines have been kept in a few national stockpiles.

“They are very limited and not in use for vaccination,” he said.

He said that a new vaccine (MVA-BN) against smallpox and monkeypox has been approved but is not yet widely available outside national stockpiles.

The News Agency of Nigeria reports that monkeypox has been reported in more than 40 countries outside of Africa, where smallpox was virtually unknown until May 2022,

According to the WHO, from January to June 22, 42 countries across five regions have reported a cumulative total of 3,413 confirmed cases with over 90 per cent recorded in non-endemic countries.

WHO European Region

The WHO European Region topped the infection with 2,933 cases, representing 86 per cent of the total cases, followed by the Region of the Americas with 381, amounting to 11 per cent.

African Region

The African Region came third on the log with 73 cases, representing two per cent of the global cases reported from six countries, with Nigeria topping the list.

Democratic Republic

Nigeria is followed by the Democratic Republic of the Congo, the Central African Republic, Ghana, Cameroon, and Congo.

Meanwhile, the monkeypox emergency committee convened by the WHO began its deliberations in Geneva.

The experts represented therein must assess whether this is an “emergency of international concern”, the highest alert level that the WHO can impose. It last did this when Sars-CoV-2 appeared on Jan. 30.

NewsSourceCredit: NAN

bet9ja mobile app sahara hausa shortner Blogger downloader